Latest Insights

UK-based Laverock Therapeutics Expands Gene-Silencing Technology to Tackle Multiple Disease Areas

Laverock Therapeutics, a UK company based at the Stevenage Bioscience Catalyst, is advancing its programmable gene-silencing platform, GEiGS, aimed at simultaneously silencing multiple genes. The technology uses reprogrammed microRNAs (miRNAs)—molecules …

Continue ›››

Healthcare’s Cybersecurity Crisis: A Growing Threat Amid Outdated Technology

As healthcare systems embrace digital transformation, the increased reliance on connected devices, platforms, and remote work environments has significantly expanded their vulnerability to cyberattacks. According to the SonicWall threat brief …

Continue ›››

Looking Back: How Etcembly's ETCh Study is Uncovering New Cancer Targets from Survivors

Despite advances in medical science, finding a cure for cancer remains an elusive goal. Currently, only half of all people diagnosed with cancer survive for ten years or more, and …

Continue ›››

Generate Biomedicines Enters Up to $1 Billion Multi-Target Collaboration with Novartis to Use Generative AI for Protein Design

Generate:Biomedicines has announced a multi-target collaboration with Novartis to develop protein therapeutics using its generative AI platform. The deal, valued at over $1 billion with an upfront payment of $65 …

Continue ›››

UK-based Laverock Therapeutics Expands Gene-Silencing Technology to Tackle Multiple Disease Areas

Healthcare’s Cybersecurity Crisis: A Growing Threat Amid Outdated Technology

Looking Back: How Etcembly's ETCh Study is Uncovering New Cancer Targets from Survivors

Generate Biomedicines Enters Up to $1 Billion Multi-Target Collaboration with Novartis to Use Generative AI for Protein Design

Immusoft Announces Positive Data for First Engineered B Cell Therapy in Clinical Trial

ImageBloom Launches Patient Recruitment Marketplace for Clinical Trials

Aston University Scientists Develop Gallium-Infused Glass Nanoparticles to Treat Osteosarcoma

Vortioxetine Shows Potential in Glioblastoma Treatment, Clinical Trials Planned

Dandelion Health Launches AI Marketplace to Speed Up Clinical Trials with Real-World Data

Asimov Unveils AI-Powered AAV Edge Platform for Gene Therapy Design and Manufacturing

Insilico Medicine Reports Positive Phase IIa Results for AI-Designed Drug Targeting Idiopathic Pulmonary Fibrosis

Arzeda Raises $38M to Meet Strong Market Demand for Better Tasting Stevia